Enox Biopharma Inc SEC Filings

Filed On	Filing
15 Mar 2011	FORM 15 OF ENOX BIOPHARMA, INC.
03 Jan 2011	Form 4/A: Avniel Amir, Director Granted 880,571 Option (right to buy)
03 Jan 2011	Form 4: Rewcastle John Cameron, Chief Executive Officer Acquired 1,327,292 Employee Option (Open Market Purchase)
03 Jan 2011	Form 3: Rewcastle John Cameron, Chief Executive Officer No securities owned
03 Jan 2011	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
15 Nov 2010	QTRLY REPORT FOR THE QTR ENDED 9-30-10
05 Nov 2010	Form 4: David Itamar, Chief Financial Officer Disposed of 201,122 shares (Open Market Purchase) ($60.3K)
04 Nov 2010	8-K: Departure/Election of Directors or Officers; Compensation
18 Aug 2010	Form 4: David Itamar, Chief Financial Officer Bought 201,122 shares ($60.3K) · Bought 25,000 shares ($50K) · Acquired 12,500 Warrant (Open Market Purchase)
18 Aug 2010	Form 4: Avniel Amir, Director Bought 25,000 shares ($50K) · Acquired 12,500 Warrant (Open Market Purchase)
16 Aug 2010	QTRLY REPORT FOR THE QTR ENDED 6-30-10
14 Jul 2010	UPLOAD
08 Jul 2010	CORRESP
30 Jun 2010	UPLOAD
24 Jun 2010	Form 4: David Itamar, Chief Financial Officer Granted 1,000,000 Option (right to buy)
22 Jun 2010	Form 4: Av-Gay Yossef, Director Granted 800,000 Option (right to buy)
22 Jun 2010	Form 4: Avniel Amir, Director Granted 1,886,938 Option (right to buy)
17 May 2010	QTRLY REPORT FOR THE QTR ENDED 3-31-10
06 May 2010	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
15 Apr 2010	ANNUAL REPORT FOR THE YEAR ENDED 12-31-09

Comments